Trial intelligence / Profile preview

PRP vs PRP+Betamethasone vs Betamethasone for Upper Trapezius Myofascial Pain Syndrome

NCT07547605Phase 4Recruiting

Sponsor
University of Kyrenia
Start
May 2026
Primary completion
Dec 2026
Modality
Orthosteric Ligands, Adoptive Cell Transfer
Countries
1
01

Overview

A Phase 4 trial of platelet-rich plasma injection, betamethasone in myofascial pain syndrome (MPS), sponsored by University of Kyrenia. Started May 2026; status: recruiting.

02

Drugs

platelet-rich plasma injectionbetamethasone
03

Conditions

myofascial pain syndrome (MPS)

Beyond the preview

Go deeper on NCT07547605.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07547605.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call